(Q39673740)

13 September 2017

title

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells (English)

1 reference

13 September 2017

1 reference

lymphoblastic leukemia

1 reference

6

Domenico Ribatti

1 reference

13 September 2017

1

Claudia Cocco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20671120

13 June 2024

4

Emma Di Carlo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20671120

13 June 2024

8

Giuseppe Basso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20671120

13 June 2024

9

Irma Airoldi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20671120

13 June 2024

author name string

Sara Canale

2

1 reference

13 September 2017

Chiara Frasson

3

1 reference

13 September 2017

Emanuela Ognio

5

1 reference

13 September 2017

Ignazia Prigione

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

29 July 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

116

1 reference

13 September 2017

issue

19

1 reference

13 September 2017

page(s)

3887-3898

1 reference

The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.

13 September 2017

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI200420303

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

13 June 2024

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells

13 June 2024

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

13 June 2024

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells

13 June 2024

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

13 June 2024

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

13 June 2024

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Interleukin-23 drives innate and T cell-mediated intestinal inflammation

13 June 2024

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis

13 June 2024

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Emerging role of IL-23/IL-17 axis in H pylori-associated pathology

13 June 2024

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Swords into plowshares: IL-23 repurposes tumor immune surveillance

13 June 2024

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

IL-23 promotes tumour incidence and growth

13 June 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

A cytokine-mediated link between innate immunity, inflammation, and cancer

13 June 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

13 June 2024

14

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.

13 June 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

13 June 2024

17

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Antitumor and antimetastatic activity of IL-23

13 June 2024

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

13 June 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant

13 June 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.

13 June 2024

21

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects

13 June 2024

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.

13 June 2024

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

13 June 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

13 June 2024

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

13 June 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

13 June 2024

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

RAS is regulated by the let-7 microRNA family

13 June 2024

28

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma

13 June 2024

29

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

13 June 2024

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Impaired microRNA processing enhances cellular transformation and tumorigenesis

13 June 2024

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

MicroRNA expression profiles classify human cancers

13 June 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

New methodologic approaches for immunophenotyping acute leukemias.

13 June 2024

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.

13 June 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay.

13 June 2024

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.

13 June 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

miR-15 and miR-16 induce apoptosis by targeting BCL2

13 June 2024

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members.

13 June 2024

40

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli.

13 June 2024

41

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells

13 June 2024

42

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Endogenous IL-12 triggers an antiangiogenic program in melanoma cells.

13 June 2024

43

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

13 June 2024

44

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells

13 June 2024

45

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells

13 June 2024

46

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

13 June 2024

47

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells

13 June 2024

48

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

13 June 2024

49

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

13 June 2024

Cancer cell cycles

50

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2009-10-248245

13 June 2024

Identifiers

1 reference

13 September 2017

1 reference